bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - zāles obstruktīvu elpceļu slimību, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - zāles obstruktīvu elpceļu slimību, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
adakveo
novartis europharm limited - crizanlizumab - anēmija, sirpjveida šūna - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.
kesimpta
novartis ireland ltd - ofatumumabs - multiplā skleroze, recidivējoši-pārskaitot - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
anafranil 10 mg apvalkotās tabletes
novartis pharma gmbh, germany - klomipramīna hidrohlorīds - apvalkotās tabletes - 10 mg
sandostatin 100 mikrogrami/1 ml šķīdums injekcijām/infūzijām
novartis pharma gmbh, germany - oktreotīds - Šķīdums injekcijām/infūzijām - 0,1 mg/ml
sirdalud 4 mg tabletes
novartis s.r.o., czech republic - tizanidīns - tablete - 4 mg
sandostatin 0,1 mg/ml šķīdums injekcijām/šķīdums infūzijām
novartis (hellas) a.e.b.e., greece - oktreotīds - Šķīdums injekcijām/infūzijām - 0,1 mg/ml
voltaren 75 mg/3 ml šķīdums injekcijām
novartis pharma gmbh, germany - diklofenaka nātrija sāls - Šķīdums injekcijām - 75 mg/3 ml